Emmes, a leading Clinical Research Organization (CRO) focused on advancing public health and biopharmaceutical innovation, has acquired Essex Management, a company that offers bioinformatics and health information technology (HIT) consulting services to various organizations.
This acquisition is part of Emmes’ ongoing growth strategy, which involves expanding its services through complementary acquisitions and organic growth. With the addition of Essex, Emmes will now be able to offer new opportunities to a wider range of government agencies and provide innovative data strategies to its biopharma clients.
The combination of Emmes and Essex will enhance Emmes’ reputation as a full-service clinical research partner with a focus on data-driven solutions. With the added expertise of Essex’s technology skills and experience, Emmes will be better equipped to address global health challenges and provide cutting-edge solutions to its clients.
Essex’s recognition as a technology catalyst in the life sciences, combined with Emmes’ successful partnerships with the National Cancer Institute (NCI) and other public sector clients, will create a powerful alliance that will open new avenues of growth.